CAFs and T cells interplay: The emergence of a new arena in cancer combat

Biomed Pharmacother. 2024 Aug:177:117045. doi: 10.1016/j.biopha.2024.117045. Epub 2024 Jul 1.

Abstract

The interaction between the immune system and the tumor matrix has a huge impact on the progression and treatment of cancer. This paper summarizes and discusses the crosstalk between T cells and cancer-associated fibroblasts (CAFs). CAFs can also produce inhibitors that counteract the function of T cells and promote tumor immune escape, while T cells can also engage in complex two-way interactions with CAFs through direct cell contact, the exchange of soluble factors such as cytokines, and the remodeling of the extracellular matrix. Precise targeted intervention can effectively reverse tumor-promoting crosstalk between T cells and CAFs, improve anti-tumor immune response, and provide a new perspective for cancer treatment. Therefore, it is important to deeply understand the mechanism of crosstalk between T cells and CAFs. This review aims to outline the underlying mechanisms of these interactions and discuss potential therapeutic strategies that may become fundamental tools in the treatment of cancer, especially hard-to-cure cancers.

Keywords: CAF; Cancer; Immune; T cell; Therapeutic target.

Publication types

  • Review

MeSH terms

  • Animals
  • Cancer-Associated Fibroblasts* / drug effects
  • Cancer-Associated Fibroblasts* / immunology
  • Cancer-Associated Fibroblasts* / metabolism
  • Cancer-Associated Fibroblasts* / pathology
  • Cell Communication
  • Cytokines / immunology
  • Cytokines / metabolism
  • Extracellular Matrix / metabolism
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / immunology
  • Neoplasms* / pathology
  • T-Lymphocytes* / immunology
  • Tumor Escape / drug effects
  • Tumor Microenvironment* / immunology

Substances

  • Cytokines